BRAF and thyroid nodule: To investigate the malignant risk of ultrasound-guided fine-needle aspiration (UG-FNA) cytology-diagnosed Bethesda III thyroid nodules and the significance of combined BRAF V600E mutation testing, and to establish a clinically actionable algorithm integrating cytomorphologic and molecular features.